| 000 | 01750 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250517021425.0 | ||
| 264 | 0 | _c20160107 | |
| 008 | 201601s 0 0 eng d | ||
| 022 | _a1873-3476 | ||
| 024 | 7 |
_a10.1016/j.ijpharm.2015.03.002 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGeboers, Sophie | |
| 245 | 0 | 0 |
_aIntestinal behavior of the ester prodrug tenofovir DF in humans. _h[electronic resource] |
| 260 |
_bInternational journal of pharmaceutics _cMay 2015 |
||
| 300 |
_a131-7 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Study; Journal Article | ||
| 650 | 0 | 4 |
_aAdenine _xadministration & dosage |
| 650 | 0 | 4 | _aAdministration, Oral |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aBiotransformation |
| 650 | 0 | 4 | _aChemistry, Pharmaceutical |
| 650 | 0 | 4 | _aCross-Over Studies |
| 650 | 0 | 4 | _aDrug Stability |
| 650 | 0 | 4 |
_aDuodenum _xmetabolism |
| 650 | 0 | 4 |
_aFasting _xmetabolism |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFood-Drug Interactions |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aIntestinal Absorption |
| 650 | 0 | 4 |
_aIntestinal Secretions _xmetabolism |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aPhosphorous Acids _xadministration & dosage |
| 650 | 0 | 4 | _aPostprandial Period |
| 650 | 0 | 4 |
_aProdrugs _xadministration & dosage |
| 650 | 0 | 4 |
_aReverse Transcriptase Inhibitors _xadministration & dosage |
| 650 | 0 | 4 | _aTechnology, Pharmaceutical |
| 650 | 0 | 4 | _aYoung Adult |
| 700 | 1 | _aHaenen, Steven | |
| 700 | 1 | _aMols, Raf | |
| 700 | 1 | _aBrouwers, Joachim | |
| 700 | 1 | _aTack, Jan | |
| 700 | 1 | _aAnnaert, Pieter | |
| 700 | 1 | _aAugustijns, Patrick | |
| 773 | 0 |
_tInternational journal of pharmaceutics _gvol. 485 _gno. 1-2 _gp. 131-7 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.ijpharm.2015.03.002 _zAvailable from publisher's website |
| 999 |
_c24685110 _d24685110 |
||